Cell Therapeutics' Unattributed VC - II Round

Cell Therapeutics raised a round of funding on February 15, 2000.

CTI is committed to developing, acquiring, and commercializing innovative treatments for cancer. In the company's pursuit of making cancer more treatable, they are developing a diversified portfolio o…

Articles about Cell Therapeutics' Unattributed VC - II Round: